Ser47
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser47  -  p73 (human)

Site Information
EVVGGTDssMDVFHL   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 452197

In vivo Characterization
Methods used to characterize site in vivo:
2D analysis ( 1 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Disease tissue studied:
lung cancer ( 1 ) , non-small cell lung cancer ( 1 )
Relevant cell line - cell type - tissue:
293 (epithelial) [Chk1 (human)] ( 1 ) , 293 (epithelial) [p73 (human)] ( 1 ) , NCI-H1299 (pulmonary) [Chk1 (human)] ( 1 ) , NCI-H1299 (pulmonary) [p73 (human)] ( 1 )

Upstream Regulation
Putative in vivo kinases:
Chk1 (human) ( 1 )
Kinases, in vitro:
Chk1 (human) ( 1 )
Treatments:
cisplatin ( 1 ) , daunorubicin ( 1 ) , UCN-01 ( 1 )

References 

1

Gonzalez S, Prives C, Cordon-Cardo C (2003) p73alpha regulation by Chk1 in response to DNA damage. Mol Cell Biol 23, 8161-71
14585975   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2019 Cell Signaling Technology, Inc.